119 related articles for article (PubMed ID: 21304221)
1. Insulin resistance: pathophysiology and rationale for treatment.
Muntoni S; Muntoni S
Ann Nutr Metab; 2011; 58(1):25-36. PubMed ID: 21304221
[TBL] [Abstract][Full Text] [Related]
2. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.
Iannello S; Milazzo P; Belfiore F
Obes Rev; 2007 May; 8(3):231-51. PubMed ID: 17444965
[TBL] [Abstract][Full Text] [Related]
3. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
4. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
5. [Natural history of insulin resistance and hyperinsulinism in non-insulin-dependent diabetic patients].
Vague P; Raccah D
Journ Annu Diabetol Hotel Dieu; 1990; ():201-9. PubMed ID: 2195206
[No Abstract] [Full Text] [Related]
6. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420
[TBL] [Abstract][Full Text] [Related]
7. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
Pedersen O
Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
[TBL] [Abstract][Full Text] [Related]
8. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
Wysocki PJ; Wierusz-Wysocka B
Expert Rev Mol Diagn; 2010 May; 10(4):509-19. PubMed ID: 20465505
[TBL] [Abstract][Full Text] [Related]
9. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
10. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals.
Reaven GM
Endocrinol Metab Clin North Am; 2005 Mar; 34(1):49-62. PubMed ID: 15752921
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia, insulin resistance, and hypertension.
Bönner G
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
[TBL] [Abstract][Full Text] [Related]
12. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
Sugimoto K; Rashid IB; Kojima K; Shoji M; Tanabe J; Tamasawa N; Suda T; Yasujima M
Diabetes Metab Res Rev; 2008; 24(8):642-50. PubMed ID: 18973207
[TBL] [Abstract][Full Text] [Related]
13. [Insulin resistance and cardiovascular complications].
Janka HU
Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
[TBL] [Abstract][Full Text] [Related]
14. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Chen RH; Su YH; Chuang RL; Chang TY
Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
[TBL] [Abstract][Full Text] [Related]
15. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
Boden G
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes.
Klein J; Westphal S; Kraus D; Meier B; Perwitz N; Ott V; Fasshauer M; Klein HH
J Endocrinol; 2004 Nov; 183(2):299-307. PubMed ID: 15531718
[TBL] [Abstract][Full Text] [Related]
18. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
Ruan H; Pownall HJ
Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
Roden M
Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
[TBL] [Abstract][Full Text] [Related]
20. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
Rett K; Wicklmayr M; Standl E
Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
